ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?

C. Hoopes.

Center for Transplantation and Organ Failure, University of kentucky, Lexington, KY.

Meeting: 2015 American Transplant Congress

Abstract number: 66

Keywords: Lung transplantation, Outcome

Session Information

Date: Sunday, May 3, 2015

Session Name: Concurrent Session: Regulatory Issues in Transplant Administration

Session Time: 2:15pm-3:45pm

 Presentation Time: 3:03pm-3:15pm

Location: Room 118-C

Related Abstracts
  • Aggregate Impacts of the CMS CoP on Patient and Donor Characteristics
  • Transplant Certification and Quality Assessment: The Effect of Center Data Input Quality

In 2010 the pulmonary transplant program at the University of Kentucky entered a Systems Improvement Agreement (SIA) with CMS as a consequence of poor performance (1 and 3 year patient survival). The university successfully completed the SIA in early 2013.

We have reviewed the impact of the SIA on four criteria: (1) was the expert peer review process sufficient, accurate, and effective in identifying the “root cause” of poor performance, (2) were the implemented policy and personnel changes “institutionalized” and sustainable, (3) total costs of SIA mandated procedures and policies, and (4) evidence that SIA mandated policy changes directly impacted improved performance.

Direct costs of the SIA were 860K with indirect costs exceeding 1.2 million. The expert peer review failed – as did the program – to identify inaccuracies in O/E outcomes which could have precluded program non-compliance with CMS outcome metrics. The institution failed to achieve compliance with two of five mandates within the Systems Improvement Agreement (patient “cohorts” and organizational design of ICU care). Two years after completing the SIA there are no substantial changes in program design as measured by direct program costs, additional personnel, or administrative redesign. Patient survival is compliant with CMS expectations and remains above the national average.

The SIA is an effective mechanism for informing hospital administration as to the need for organizational change. In the absence of ongoing oversight there is no organizational impetus for change sustainability. Our review suggests the SIA had little impact on subsequent program improvement and patient outcome.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Hoopes C. Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior? [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/do-cms-oversight-and-the-systems-improvement-agreement-really-change-institutional-behavior/. Accessed March 4, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.